Indonesia allows Taiwan's COVID-19 vaccine candidate to conduct clinical trial
09/13/2021 12:05 PM
Taiwanese vaccine producer Adimmune Corp. said on Monday that it has gained approval from the Indonesian government to conduct Phase 2 clinical trials for its COVID-19 vaccine candidate, with results expected to be released next year.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Ex-cop acquitted in fatal shooting of passenger in fleeing car
11/05/2024 07:08 PM - Business
Taiwan shares end up on thin turnover ahead of U.S. election
11/05/2024 06:49 PM - Society
Illegal abortion proposal shelved after opposition from women's groups
11/05/2024 06:42 PM - Society
Enterovirus epidemic reaches 10-year high for period
11/05/2024 06:24 PM - Politics
Taiwan, Idaho sign MOU to celebrate 40-year relationship
11/05/2024 06:15 PM